ワクチンの副反応

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
 Patone M, et al.〔Nat Med. 2021 Dec 14〕（査読済み）


Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England
 Andrews NJ, et al.〔Lancet Reg Health Eur. 2022 Feb;13:100260〕（査読済み）

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study
 Husby A, et al.〔BMJ. 2021 Dec 16;375:e068665〕（査読済み）

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
 Oster ME, et al.〔JAMA. 2022 Jan 25;327(4):331-340〕（査読済み）

Association Between the BNT162b2 Messenger RNA COVID-19 Vaccine and the Risk of Sudden Sensorineural Hearing Loss
 Yanir Y, et al.〔JAMA Otolaryngol Head Neck Surg. 2022 Feb 24;e214278〕（査読済み）

Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination
 Formeister EJ, et al.〔JAMA Otolaryngol Head Neck Surg. 2022 Feb 24;e214414〕（査読済み）

Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines A Systematic Review and Meta-analysis
 Chu DK, et al.〔JAMA Intern Med. 2022 Apr 1;182(4):376-385〕（査読済み）

規制機関情報


Myocarditis/pericarditis in association with COVID-19 immunisation: Case reports received by Swissmedic
 〔スイス Swissmedic. Vigilance-News Edition 27 – November 2021〕

Menstrual disorders after COVID-19 vaccination – facts, possible causes, unanswered questions
 〔スイス Swissmedic. Vigilance-News Edition 27 – November 2021〕

Menstrual disorders and postmenopausal bleeding after administration of COVID-19 vaccines
 〔オランダ Lareb（Netherlands Pharmacovigilance Centre）〕

Signal: Covid-19 vaccines and hearing loss and tinnitus
 〔WHO Pharmaceuticals Newsletter No. 1, 2022〕

Overview of lymphadenopathy after Covid-19 Booster vaccination
 〔オランダ Lareb（Netherlands Pharmacovigilance Centre）〕

Overview of COVID-19 vaccines and VITT/TTS (Thrombosis with thrombocytopenia syndrome), update March 2022
 〔オランダ Lareb（Netherlands Pharmacovigilance Centre）〕

Overview of classical thromboembolic events (not VITT) after COVID-19 vaccination (UPDATE)
 〔オランダ Lareb（Netherlands Pharmacovigilance Centre）〕